Leach, Michael, and Williams, Paul, University of Greenwich (2023) Diazine and triazine compounds to treat cytokine storm syndrome US 2023/0165869 A1. US2023/0165869A1.

Preview

PDF (PCT patent) 43130_LEACH_Diazine_and_triazine_compounds_to_treat_cytokine_storm_syndrome_US2023_0165869A1.pdf - Published Version Download (3MB) | Preview

Abstract

The present invention relates to diazine and triazine compounds having activity as Interferon and Interleukin inhibitors, particularly Interferon-gamma, Tumour necrosis factor (86) PCT No.: PCT/GB2021/051005 (TNF)-a and Interleukin-I (3, 2, 4, 6, 8, 13 and 17 inhibitors, 371 and to the compounds for use in the treatment of cytokine (2) Date: Oct. 24, 2022 storm syndrome or cytokine release syndrome.

Item Type:	Patent
Additional Information:	2023-03-20 AS Assignment Owner name: UNIVERSITY OF GREENWICH, UNITED KINGDOM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LEACH, MIKE;WILLIAMS, PAUL;REEL/FRAME:063035/0798 Effective date: 2023-03-13
Uncontrolled Keywords:	cytokine storm syndrome; cytokine release syndrome
Subjects:	Q Science > Q Science (General) R Medicine > RS Pharmacy and materia medica
Faculty / School / Research Centre / Research Group:	Faculty of Engineering & Science Faculty of Engineering & Science > Biomedical Science Research Group Faculty of Engineering & Science > Medway Centre for Pharmaceutical Science Faculty of Engineering & Science > Medway Centre for Pharmaceutical Science > Pharmaceutical and Medicinal Science Research Group Faculty of Engineering & Science > School of Science (SCI)
Last Modified:	05 Jul 2023 09:23
URI:	http://gala.gre.ac.uk/id/eprint/43130

Actions (login required)

View Item

Downloads